Sino Biopharmaceutical Li...

PNK: SBHMY · Real-Time Price · USD
9.48
0.00 (0.00%)
At close: Apr 21, 2025, 3:37 PM

Company Description

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China.

It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others.

The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections.

It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets.

In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures.

Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients.

The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited logo
Country HK
IPO Date Sep 5, 2017
Industry Biotechnology
Sector Healthcare
Employees 24,379
CEO Y. Y. Tse

Contact Details

Address:
Office Tower
Wan Chai,
HK
Website https://www.sinobiopharm.com

Stock Details

Ticker Symbol SBHMY
Exchange PNK
Fiscal Year January - December
Reporting Currency USD
CIK Code n/a
CUSIP Number 82937X103
ISIN Number US82937X1037
Employer ID -
SIC Code n/a

Key Executives

Name Position
Chun Ling Li Chief Financial Officer
Cheung Ling Cheng Executive Vice Chairwoman of the Board
Hsin Tse Senior Vice President & Executive Director
Ping Tse Founder & Senior Executive Vice Chairman
Song Jin Vice President of Public Affairs, Medicines Policies & ESG
Y. Y. Tse Executive Chairwoman of the Board
Zhoushan Tian Executive Director

Latest SEC Filings

No SEC filings available.